MLS-2384 (free base)
MLS-2384 free base is a dual JAK/Src kinase inhibitor. MLS-2384 free base downregulates STAT3 downstream proteins c-Myc and Mcl-1. MLS-2384 free base induces Apoptosis. MLS-2384 free base exhibits anticancer activity against prostate cancer, breast cancer, skin cancer, ovarian cancer, lung cancer, and liver cancer[1].
Product Specifications
CAS Number
[1067884-45-0]
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; c-Myc; JAK; Src; STAT
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C1NC2=C(C=CC(Br)=C2)/C1=C3NC4=C(C=CC=C4)C/3=N\OCCN5CCNCC5
Molecular Formula
C22H22BrN5O2
Molecular Weight
468.35
References & Citations
[1]Liu L, et al. MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer Biol Ther. 2014 Feb;15 (2) :178-84.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Mcl-1; STAT3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1111224-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O127:H6 Argininosuccinate lyase (argH)
Ask
View Details 
MBS1111224-02 0.02 mg (Yeast)
Recombinant Escherichia coli O127:H6 Argininosuccinate lyase (argH)
Ask
View Details 
MBS1111224-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O127:H6 Argininosuccinate lyase (argH)
Ask
View Details MBS1111224-04 0.1 mg (Yeast)
Recombinant Escherichia coli O127:H6 Argininosuccinate lyase (argH)
Ask
View Details MBS1111224-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O127:H6 Argininosuccinate lyase (argH)
Ask
View Details MBS1111224-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O127:H6 Argininosuccinate lyase (argH)
Ask
View Details